Scientific issues associated with the validation of in vitro and in vivo methods for assessing endocrine disrupting chemicals

Toxicology

Volumn 181-182, Issue , 2002, Pages 389-397

  Ashby, John ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; GENISTEIN; PHYTOESTROGEN;

ARTICLE; ASSAY; NONHUMAN; PRIORITY JOURNAL; RODENT CONTROL; SENSITIVITY ANALYSIS; TECHNIQUE; VALIDATION PROCESS;

ANIMALS; BIOLOGICAL ASSAY; DIET; DIETHYLSTILBESTROL; ENDOCRINE GLANDS; ENDOCRINE SYSTEM DISEASES; ESTROGENS, NON-STEROIDAL; HUMANS; MICE; ORGAN SIZE; PHENOLS; RATS; REPRODUCIBILITY OF RESULTS; XENOBIOTICS;

ANIMALIA; RODENTIA;

EID: 0037184822     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00473-0     Document Type: Article

References (45)

1. Ashby J. Dose levels of 0.02-0.2 μg/kg/day DES are not suitable for use as a positive control in endocrine toxicity studies, Editorial. Regul. Toxicol. Pharmacol. 29:1999;235-237.
2. Ashby J. Increasing the sensitivity of the rodent uterotrophic assay to estrogens. with particular reference to bisphenol A. Environ. Health Perspect. 109:2001a;1091-1094.
3. Ashby J. Toward resolution of the divergent effects of estrogens on the prostate gland of CF1 mice. Environ. Health Perspect. 109:2001b;A109-A110.
4. Ashby J. Testing for endocrine disruption post-EDSTAC: extrapolation of low dose rodent effects to humans. Toxicol. Lett. 120:2001c;233-242.
5. Ashby J., Lefevre P.A. Preliminary evaluation of the major protocol variables for the Hershberger castrated male rat assay. Regul. Toxicol. Pharmacol. 31:2000a;92-105.
6. Ashby J., Lefevre P.A. The peripubertial male rat assay as a replacement for the Hershberger castrated male rat assay. J. Appl. Tox. 20:2000b;35-47.
7. Ashby J., Lefevre P.A., Deghenghi R., Wallis N. Replacement of surgical castration by GnRH-inhibition or Leydig cell ablation in male rat Hershberger anti-androgen assay. Reg. Tox. Pharm. 34:2001;188-203.
8. Ashby J., Tinwell H., Haseman J. Lack of effects for low dose levels of BPA and DES on the prostate gland of CF1 mice exposed in utero. Regul. Toxicol. Pharmacol. 30:1999;156-166.
9. Ashby J., Tinwell H., Lefevre P.A., Odum J., Paton D., Millward S.W., Tittensor S., Brooks A.N. Normal sexual development of rats exposed to butyl benzyl phthalate from conception to weaning. Regul. Toxicol. Pharmacol. 26:1997;102-118.
10. Cagen S.Z., Waechter J.M. Jr., Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., Joiner R.L., Shiotsuka R.N., Veenstra G.E., Harris L.R. Normal reproductive organ development in CF-1 mice following prenatal exposure to Bisphenol A. Toxicol. Sci. 50:1999;36-44.
11. Deghenghi R., Boutignon F., Wuthrich P., Lenaerts V. Antarelix (EP24332) a novel water soluble LHRH antagonist. Biomed. Pharmacother. 47:1993;107-110.
12. Elsby R., Ashby J., Sumpter J.P., Brooks A.N., Maggs J.L., Lefevre P.A., Odum J., Beresford N.A., Paton D., Park B.K. Obstacles to the prediction of estrogenicity from chemical structure: assay-mediated metabolic transformation and the apparent promiscuous nature of the estrogen receptor. Biochem. Pharm. 60:2000;1519-1530.
13. Elsby R., Maggs J.L., Ashby J., Paton D., Park K. Assessing the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. J. Pharmacol. Exp. Ther. 296:2001;329-337.
14. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., Sheehan D.M. Quantitative comparisons of in vitro assays for estrogenic activities. Environ. Health Perspect. 108:2000;723-729.
15. Fang H., Tong W., Shi L.M., Blair R., Perkins R., Branham W., Hass B.S., Xie Q., Dial S.L., Moland C.L., Sheehan D.M. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 14:2001;280-294.
16. Fialkowski, O., Merker, H.-J., Talsness, C.E., Chahoud, I., 2000. Histopathological findings in the testes of male rat offspring following prenatal exposure to a low and a high dose of bisphenol A. Proceedings of the RH Workshop, Copenhagen May 2000 (Abstract 55).
17. Ghosh D., Taylor J.A., Green J.A., Lubahn D.B. Methoxychlor stimulates estrogen-responsive mRNA in mouse uterus through a non-estrogen receptor mechanism. Endocrinology. 140:1999;3526-3533.
18. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Conner K., Zacharewski T., Safe S., McDonell D.P., Gaido K.W. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol. Molec. Cellular Endocrin. 142:1998;203-214.
19. Gray L.E. Jr., Ostby J., Monosson E., Kelce W.R. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol. Ind Health. 15:1999;48-64.
20. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Exposure to bisphenol A advances puberty. Nature. 401:1999;763-764.
21. Kanno J., Onyon L., Haseman J., Fenner-Crisp P., Ashby J., Owens W. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in-vivo estrogenic responses: phase one. Environ. Health Perspect. 109:2001;785-794.
22. Lee P.C. Disruption of male reproductive tract development by administration of the xenoestrogen, nonylphenol, to male newborn rats. Endocrine. 9:1998;105-111.
23. Long X., Steinmetz R., Ben-Jonathan N., Caperell-Grant A., Young P.C.M., Nephew K.P., Bigsby R.M. Strain differences in vaginal responses to the xenoestrogen bisphenol A. Environ. Health Perspect. 108:2000;243-247.
24. Markey C.M., Michaelson C.L., Veson E.C., Sonnenschein C., Soto A.M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 109:2001;55-60.
25. Nagel S., vom Saal F.S., Thayer K., Dhar M., Boechler M., Welshons W. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 105:1997;70-76.
26. Odum J., Lefevre P.A., Tittensor S., Paton D., Harris C.A., Routledge E.D., Sumpter J.P., Ashby J. The rodent uterotrophic assay; critical protocol features, studies with nonylphenols and comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol. 25:1997;176-188.
27. Odum J., Ashby J. NP Neonatal exposure of male rats to nonylphenol has no effect on the reproductive tract. Toxicol. Sci. 56:2000;400-404.
28. Odum J., Pyrah I., Soames A., Foster J., Van Miller J., Joiner R., Ashby J. Effects of p-nonylphenol (NP) and diethylstilbestrol (DES) on the Alderley Park (Alpk) rat: comparison of mammary gland and uterus sensitivity following administration by either oral gavage or subcutaneously implanted mini-pumps. J. Appl. Toxicol. 19:1999;367-378.
29. Odum J., Tinwell H., Jones K., Van Miller J.P., Joiner R.L., Tobin G., Kawasaki H., Deghenghi R., Ashby J. Effect of rodent diets on the sexual development of the rat. Toxicol. Sci. 61:2001;115-127.
30. Sharpe R.M., Fisher J.S., Millar M.M., Jobling S., Sumpter J.P. Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 103:1995;1136-1143.
31. Sharpe R.M., Turner K.J., Sumpter J.P. Endocrine disruptors and testis development. Environ. Health Perspect. 106:1998;A220-A221.
32. Shelby M.D. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity. Mutation Res. 352:1996;159-167.
33. Shelby M.D., Newbold R.R., Tully D.B., Chae K., Davis V.L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104:1996;1296-1300.
34. Shi L.M., Fang H., Tong W., Wu J., Perkins R., Blair R.M., Branham W.S., Dial S.L., Moland C.L., Sheehan D.M. QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci. 41:2001;186-195.
35. Sohoni P., Lefevre P.A., Ashby J., Sumpter J.P. Possible androgenic/anti-androgenic activity of the fungicide fenitrothione. J. Appl. Toxicol. 21:2001;173-178.
36. Spearow J.L., Doemeny P., Sera R., Leffler R., Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science. 285:1999;1259-1261.
37. Steinmetz R., Brown N.G., Allen D.L., Bigsby R.M., Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology. 138:1997;1780-1786.
38. Talsness, C.E., Chahoud, I., 2000. Histopathological findings in the vagina of rat female offspring following prenatal exposure to a low and a high dose of bisphenol A. Proceedings of the RH Workshop, Copenhagen May 2000 (Abstract 56).
39. Tamura H., Maness S.C., Reischmann K., Dorman D.C., Gray L.E., Gaido K.W. Androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicol. Sci. 60:2001;56-62.
40. Thigpen J.E., Setchell K.D.R., Goelz M.F., Forsythe D.B. The phytoestrogen content of rodent diets. Environ. Health Perspect. 107:1999;182-183.
41. Tinwell H., Joiner R., Pate I., Ashby J. Uterotrophic activity of Bisphenol A (BPA) in the immature mouse. Regul. Toxicol. Pharmacol. 32:2000;118-126.
42. Tyl R.W., Myers C.B., Marr M.C., Brine D.R., Fail P.A., Seely J.C., Van Miller J.P. Two-generation reproduction study with para-tert-octylphenol in rats. Regul. Toxicol. Pharmacol. 30:1999;81-95.
43. Vom Saal, F.S., 2000. Low dose effects of bisphenol A and estrogenic drugs. Proceedings of the RH Workshop, Copenhagen May 2000 (Session 5 Abstract).
44. Vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V.K., Parmigiani S., Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. USA. 94:1997;2056-2061.
45. Zelinski W.J., Vandenbergh J.G. Effect of intrauterine position and social density on age of first reproduction in the female house mouse (Mus musculus). J. Comp. Psychol. 105:1991;134-139.